PL3908570T3 - Embonian ketaminy i jego zastosowanie - Google Patents

Embonian ketaminy i jego zastosowanie

Info

Publication number
PL3908570T3
PL3908570T3 PL20739053.5T PL20739053T PL3908570T3 PL 3908570 T3 PL3908570 T3 PL 3908570T3 PL 20739053 T PL20739053 T PL 20739053T PL 3908570 T3 PL3908570 T3 PL 3908570T3
Authority
PL
Poland
Prior art keywords
ketamine pamoate
pamoate
ketamine
Prior art date
Application number
PL20739053.5T
Other languages
English (en)
Inventor
Tong-Ho Lin
Yung-Shun WEN
Chia-Hsien Chen
Wei-Ju Chang
Original Assignee
Alar Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alar Pharmaceuticals Inc. filed Critical Alar Pharmaceuticals Inc.
Publication of PL3908570T3 publication Critical patent/PL3908570T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL20739053.5T 2019-01-11 2020-01-10 Embonian ketaminy i jego zastosowanie PL3908570T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962791058P 2019-01-11 2019-01-11
US201962871763P 2019-07-09 2019-07-09
PCT/CN2020/071404 WO2020143762A1 (en) 2019-01-11 2020-01-10 Ketamine pamoate and use thereof

Publications (1)

Publication Number Publication Date
PL3908570T3 true PL3908570T3 (pl) 2024-07-01

Family

ID=71521952

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20739053.5T PL3908570T3 (pl) 2019-01-11 2020-01-10 Embonian ketaminy i jego zastosowanie

Country Status (27)

Country Link
US (1) US11981617B2 (pl)
EP (1) EP3908570B1 (pl)
JP (1) JP7451538B2 (pl)
KR (1) KR102892857B1 (pl)
CN (1) CN113423686B (pl)
AU (1) AU2020206826B2 (pl)
CL (1) CL2021001803A1 (pl)
CO (1) CO2021006884A2 (pl)
DK (1) DK3908570T3 (pl)
ES (1) ES2974259T3 (pl)
FI (1) FI3908570T3 (pl)
HR (1) HRP20240255T1 (pl)
HU (1) HUE065684T2 (pl)
LT (1) LT3908570T (pl)
MX (1) MX2021006029A (pl)
MY (1) MY203905A (pl)
PE (1) PE20211550A1 (pl)
PH (1) PH12021551157A1 (pl)
PL (1) PL3908570T3 (pl)
PT (1) PT3908570T (pl)
RS (1) RS65271B1 (pl)
SG (1) SG11202104792SA (pl)
SI (1) SI3908570T1 (pl)
SM (1) SMT202400100T1 (pl)
TW (1) TWI827783B (pl)
WO (1) WO2020143762A1 (pl)
ZA (1) ZA202103132B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE056378T2 (hu) 2013-09-13 2022-02-28 Univ Chiba Nat Univ Corp R-Ketamin és sójának alkalmazása gyógyszerekként
ES2907692T3 (es) 2017-12-29 2022-04-26 Celon Pharma Sa Composición de ketamina de polvo seco para su administración por vía pulmonar en la depresión resistente al tratamiento
US11980595B2 (en) 2018-02-15 2024-05-14 National University Corporation Chiba University Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases
WO2019213551A1 (en) 2018-05-04 2019-11-07 Perception Neuroscience, Inc. Methods of treating substance abuse
PH12022550775A1 (en) * 2019-12-20 2023-08-23 Alar Pharmaceuticals Inc Long-acting injectable formulations of ketamine pamoate salts
US20210322669A1 (en) * 2020-04-16 2021-10-21 Invictus Health, Inc. Method for treatment of traumatic brain injuries
CN112263572A (zh) * 2020-11-17 2021-01-26 厦门大学附属翔安医院 右旋氯胺酮在制备治疗脱髓鞘疾病药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1248869A2 (en) 2000-01-07 2002-10-16 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
US20080293695A1 (en) 2007-05-22 2008-11-27 David William Bristol Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
US9421266B2 (en) * 2007-05-22 2016-08-23 Pisgah Laboratories, Inc. Safety of pseudoephedrine drug products
JO2857B1 (en) 2008-06-16 2015-03-15 سانوفي أفينتس Vinyl pipers with modified activity of tumor-resistant TNF
JO3227B1 (ar) 2011-09-08 2018-03-08 Otsuka Pharma Co Ltd مشتقات بنزو ثيوفين بها استبدال ببرازين كعوامل مضادة للذهان
JP2014196292A (ja) 2013-03-07 2014-10-16 大塚製薬株式会社 医薬
CN106562952B (zh) * 2015-10-09 2020-06-09 江阴安博生物医药有限公司 氯胺酮在治疗重性抑郁障碍中的应用
WO2017167180A1 (zh) 2016-03-29 2017-10-05 上海华汇拓医药科技有限公司 沃替西汀的帕莫酸盐及其晶型
EP3558279A4 (en) * 2016-12-26 2020-12-02 Cellix Bio Private Limited COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN
PL3737665T3 (pl) * 2018-01-10 2026-04-20 XWPharma Ltd. Proleki ketaminy, ich kompozycje i zastosowania

Also Published As

Publication number Publication date
MX2021006029A (es) 2021-09-23
DK3908570T3 (da) 2024-02-26
AU2020206826A1 (en) 2021-06-03
CN113423686A (zh) 2021-09-21
CN113423686B (zh) 2023-08-22
BR112021013340A2 (pt) 2021-09-14
HRP20240255T1 (hr) 2024-05-24
PT3908570T (pt) 2024-03-15
CO2021006884A2 (es) 2021-06-10
EP3908570B1 (en) 2023-12-13
ZA202103132B (en) 2024-11-27
FI3908570T3 (fi) 2024-02-13
MY203905A (en) 2024-07-24
JP7451538B2 (ja) 2024-03-18
KR20210116517A (ko) 2021-09-27
NZ775810A (en) 2024-07-26
PH12021551157A1 (en) 2021-11-03
LT3908570T (lt) 2024-03-12
ES2974259T3 (es) 2024-06-26
HUE065684T2 (hu) 2024-06-28
TW202042796A (zh) 2020-12-01
SI3908570T1 (sl) 2024-04-30
CA3118954A1 (en) 2020-07-16
CL2021001803A1 (es) 2021-12-24
EP3908570A4 (en) 2022-10-19
EP3908570A1 (en) 2021-11-17
RS65271B1 (sr) 2024-03-29
KR102892857B1 (ko) 2025-11-27
SMT202400100T1 (it) 2024-05-14
US20220119338A1 (en) 2022-04-21
JP2022518003A (ja) 2022-03-11
TWI827783B (zh) 2024-01-01
SG11202104792SA (en) 2021-06-29
PE20211550A1 (es) 2021-08-16
AU2020206826B2 (en) 2024-05-02
US11981617B2 (en) 2024-05-14
WO2020143762A1 (en) 2020-07-16

Similar Documents

Publication Publication Date Title
IL294052B2 (en) Fluoroalkyl oxadiazoles and their uses
SG11202104792SA (en) Ketamine pamoate and use thereof
IL285177A (en) compounds and their use
IL286497A (en) compounds and their use
IL292692B1 (en) Mrgprx2 antagonists and their uses
IL282350A (en) Bernani-RGMC inhibitors and their use
IL277502A (en) Compounds and uses for them
ZA202109518B (en) Imidazopyrimidines as eed inhibitors and the use thereof
IL287782A (en) 33cd-binding polypeptides and their uses
IL291499A (en) Azaquinoline compounds and their uses
IL277749A (en) Palladianolide compounds and their use
SG11202108079RA (en) Compounds and uses thereof
IL287503A (en) Thio-semicarbazide compounds and their use
IL284764A (en) compounds and their uses
GB201801102D0 (en) New compounds and uses
IL279483A (en) Cyanotriazole compounds and their uses
GB201812561D0 (en) Biomarkers and uses thereof
GB201806042D0 (en) Biomarkers and uses thereof
IL280644A (en) Magnesium serine compound and its use
PL3774141T3 (pl) Hydrauliczny uchwyt rozprężny i jego zastosowanie
IL288828A (en) Binding factors - cd38 and their use
ZA202201239B (en) Aminothiolester compounds and uses thereof
IL280369A (en) Myokines and their uses
IL278919A (en) Combinations comprising tropifexor and cenicriviroc
GB201906914D0 (en) Substituted naphtahlene diimdes and their use